News
![DGAP-News: Newron weitet internationale Studie zur Untersuchung der Krankheitslast von Rett-Syndrom auf Europa und Australien aus](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
DGAP-News: Newron weitet internationale Studie zur Untersuchung der Krankheitslast von Rett-Syndrom auf Europa und Australien aus
DGAP-News: Newron weitet internationale Studie zur Untersuchung der Krankheitslast von Rett-Syndrom auf Europa und Australien aus
![Form 8.3 - The Vanguard Group, Inc.: AbbVie plc](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
![DGAP-News: Burcon NutraScience Corp.: Burcon nimmt Handel am OTCQB(R) Venture Market in den USA auf](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
DGAP-News: Burcon NutraScience Corp.: Burcon nimmt Handel am OTCQB(R) Venture Market in den USA auf
DGAP-News: Burcon NutraScience Corp.: Burcon nimmt Handel am OTCQB(R) Venture Market in den USA auf
![DGAP-News: Burcon NutraScience Corp.: Burcon Commences Trading on the OTCQB(R) Venture Market in the U.S.](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
DGAP-News: Burcon NutraScience Corp.: Burcon Commences Trading on the OTCQB(R) Venture Market in the U.S.
DGAP-News: Burcon NutraScience Corp.: Burcon Commences Trading on the OTCQB(R) Venture Market in the U.S.
![Form 8.3 - The Vanguard Group, Inc.: AbbVie plc](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
![DGAP-News: 4SC to present at the World Congress of Cutaneous Lymphomas in Barcelona, Spain](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
DGAP-News: 4SC to present at the World Congress of Cutaneous Lymphomas in Barcelona, Spain
DGAP-News: 4SC to present at the World Congress of Cutaneous Lymphomas in Barcelona, Spain
![DGAP-News: 4SC präsentiert auf dem World Congress of Cutaneous Lymphomas in Barcelona, Spanien](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
DGAP-News: 4SC präsentiert auf dem World Congress of Cutaneous Lymphomas in Barcelona, Spanien
DGAP-News: 4SC präsentiert auf dem World Congress of Cutaneous Lymphomas in Barcelona, Spanien
![Form 8.3 - The Vanguard Group, Inc.: AbbVie plc](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
![Form 8.3 - The Vanguard Group, Inc.: AbbVie plc](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
![DGAP-News: CO.DON AG erweitert ihre Produktpalette um Auftragsherstellung](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
DGAP-News: CO.DON AG erweitert ihre Produktpalette um Auftragsherstellung
DGAP-News: CO.DON AG erweitert ihre Produktpalette um Auftragsherstellung
![DGAP-News: CO.DON AG adds contract manufacturing to its product portfolio](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
DGAP-News: CO.DON AG adds contract manufacturing to its product portfolio
DGAP-News: CO.DON AG adds contract manufacturing to its product portfolio
![Form 8.3 - The Vanguard Group, Inc.: AbbVie plc](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
![Form 8.3 - The Vanguard Group, Inc.: AbbVie plc](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
![Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
![Form 8.3 - The Vanguard Group, Inc.: AbbVie plc](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
![Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult
Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult
![DGAP-News: Formycon informiert über aktuellen Status im Zulassungsprozess des Lucentis(R)* Biosimilar-Kandidaten FYB201](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
DGAP-News: Formycon informiert über aktuellen Status im Zulassungsprozess des Lucentis(R)* Biosimilar-Kandidaten FYB201
DGAP-News: Formycon informiert über aktuellen Status im Zulassungsprozess des Lucentis(R)* Biosimilar-Kandidaten FYB201
![DGAP-News: Formycon informs about the current Status of the BLA Review Process of the Lucentis(R)* Biosimilar Candidate FYB201](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
DGAP-News: Formycon informs about the current Status of the BLA Review Process of the Lucentis(R)* Biosimilar Candidate FYB201
DGAP-News: Formycon informs about the current Status of the BLA Review Process of the Lucentis(R)* Biosimilar Candidate FYB201
DGAP-News: MorphoSys Initiiert Expanded Access Program für Tafasitamab in den USA
DGAP-News: MorphoSys Initiiert Expanded Access Program für Tafasitamab in den USA
DGAP-News: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.
DGAP-News: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.
![Form 8.3 - The Vanguard Group, Inc.: AbbVie plc](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
![DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2019 (IFRS)](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2019 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2019 (IFRS)
![Form 8.3 - The Vanguard Group, Inc.: AbbVie plc](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
![DGAP-News: CO.DON AG: CO.DON AG launcht neue Firmenwebsite](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
DGAP-News: CO.DON AG: CO.DON AG launcht neue Firmenwebsite
DGAP-News: CO.DON AG: CO.DON AG launcht neue Firmenwebsite
![DGAP-News: CO.DON AG: CO.DON AG launches new website](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
DGAP-News: CO.DON AG: CO.DON AG launches new website
DGAP-News: CO.DON AG: CO.DON AG launches new website